Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Arterial Occlusive Diseases

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Arterial Occlusive Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manych, M1
Adeleine, P; Canet, E; Corot, C; Cremillieux, Y; Douek, PC; Hernandez-Hoyos, M; Marchand, B; Orkisz, M; Robert, P; Roux, JP1

Other Studies

2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Arterial Occlusive Diseases

ArticleYear
[Arterial stenoses - diagnostic comparison of Gd-DOTA enhanced MRA and TOF-MRA].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2012, Volume: 184, Issue:11

    Topics: Adult; Arterial Occlusive Diseases; Contrast Media; Coronary Angiography; Female; Femoral Artery; Heterocyclic Compounds; Humans; Iliac Artery; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Republic of Korea; Sensitivity and Specificity; United States

2012
Standardized MR protocol for the evaluation of MRA sequences and/or contrast agents effects in high-degree arterial stenosis analysis.
    Magma (New York, N.Y.), 2002, Volume: 14, Issue:3

    Topics: Arterial Occlusive Diseases; Arteries; Constriction, Pathologic; Dose-Response Relationship, Drug; Heterocyclic Compounds; Humans; Magnetic Resonance Angiography; Models, Cardiovascular; Organometallic Compounds; Phantoms, Imaging; Quality Control; Reproducibility of Results; Sensitivity and Specificity

2002